Efficacy and safety of COVID-19 vaccination in patients with cirrhosis

Table 2 Outcomes by group (n [per patient-yr])

	Vaccinated (n = 33.8 patient-yr)	Unvaccinated (n = 82.1 patient-yr)	P value
COVID-19 cases
Total	4 (11.8%)/3 (8.9%)1	24 (29.2%)	0.035/0.0131
Mild	1 (3.0%)	7 (8.5%)	0.260
Moderate	3 (8.9%)/2 (5.9%)1	5 (6.1%)	0.431/0.6661
Severe	0	12 (14.6%)	0.012
Death
Overall	1 (3.0%)	14 (17.1%)	0.001
Associated with COVID-19	0	10 (12.2%)	0.012
Liver-related	1 (3.0%)	4 (4.9%)	0.135
Non-COVID-19 complications (cases)
Liver decompensation	4 (11.9%)	21 (25.6%)	0.077
Bleeding esophageal varices	2 (5.9%)	8 (9.7%)	0.394
Myocardial infarction	0	1 (1.2%)	0.707
Pulmonary embolism	0	1 (1.2%)	0.707
Stroke	0	0	-
Transient ischemic attack	1 (3.0%)	0	0.293
Abdominal thrombosis	0	0	-

¹All vaccinated/fully vaccinated. COVID-19: Coronavirus disease 2019.